Cipro vs. Macrobid

See how Cipro and Macrobid compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Cipro treats a much wider range of infections than Macrobid, including kidney, bone, and respiratory infections, while Macrobid only treats bladder infections.

  • Both list nausea and diarrhea among their common side effects, but Cipro carries a boxed warning for tendon rupture and nerve damage that Macrobid does not.

  • Macrobid is generally the first choice for a simple bladder infection, while Cipro is usually saved for infections without safer treatment options.

Cipro vs. Macrobid Drug Summary

Cipro

Cipro (ciprofloxacin) is a fluoroquinolone antibiotic used for a wide range of bacterial infections, including complicated and uncomplicated UTIs, skin, bone, and respiratory infections. It is taken as a tablet every 12 hours, with the dose and length of treatment depending on the type of infection.

Macrobid

Macrobid (nitrofurantoin) is a urinary anti-infective used specifically for acute, uncomplicated bladder infections caused by E. coli or S. saprophyticus. It is taken as a capsule every 12 hours for 7 days and works only in the urinary tract, not for kidney infections or infections elsewhere in the body.

Cipro vs. Macrobid Side Effects

Cipro

Most common
diarrhea (up to 4.8%)
nausea (up to 2.7%)
vomiting (up to 4.8%)
rash (up to 1.8%)

Macrobid

Most common
diarrhea (up to 1%)
nausea (up to 8%)
headache (up to 6%)
flatulence (up to 1.5%)

Cipro vs. Macrobid Dosage

Cipro

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 250 mg every 12 hours At the start
Maximum dose 750 mg every 12 hours If needed
Dose changes 2 increases As tolerated

Macrobid

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 100 mg every 12 hours Days 1-7
Maximum dose 100 mg every 12 hours Same as starting
Dose changes None Fixed dose

Cipro vs. Macrobid Indications

Cipro

Cipro is FDA-approved for a broad range of bacterial infections beyond the urinary tract, including skin, bone, joint, respiratory, and abdominal infections, plus specific uses like anthrax exposure and typhoid fever. Because of its boxed warning, current FDA guidance says it should be reserved for infections without safer alternative options, especially uncomplicated UTIs.

  • Complicated and uncomplicated UTIs

  • Chronic bacterial prostatitis

  • Skin, bone, and joint infections

  • Respiratory and abdominal infections

Macrobid

Macrobid is FDA-approved only for acute, uncomplicated UTIs (cystitis) caused by susceptible E. coli or S. saprophyticus, not for kidney infections or infections outside the bladder. Doctors also prescribe it off-label at a lower dose for long-term prevention of recurrent UTIs, though this use isn't FDA-approved.

  • Acute uncomplicated UTIs (cystitis)

  • Caused by E. coli or S. saprophyticus

  • Off-label: recurrent UTI prevention

  • Not approved for kidney infections

Cipro vs. Macrobid Pros and Cons

Cipro

Cipro's broad spectrum and ability to reach therapeutic blood levels make it useful for infections outside the bladder, such as kidney and bone infections. That same broad reach comes with a boxed warning for tendon and nerve damage that Macrobid does not carry, so it is generally reserved for infections without safer options.

Pros

  • Treats infections beyond the bladder, including kidney

  • Short 3-day course for uncomplicated UTIs

  • Reaches therapeutic levels in blood and tissue

  • Generic often costs $10 to $20 per course

Cons

  • Boxed warning: tendon rupture, nerve, and CNS effects

  • FDA says reserve for infections without other options

  • Interacts with many drugs, dairy, and antacids

  • Linked to increased risk of C. diff infection

Macrobid

Macrobid stays concentrated in urine and works well for uncomplicated bladder infections without much systemic drug exposure. It cannot treat kidney infections or infections outside the urinary tract, and it isn't safe for patients with reduced kidney function.

Pros

  • Still reliably effective against E. coli after decades

  • Minimal systemic absorption limits some side effects

  • Used long-term at low dose to prevent recurrent UTIs

  • No boxed warning for tendon or nerve damage

Cons

  • Only treats bladder infections, not kidney infections

  • Unsafe for patients with reduced kidney function

  • Rare but serious lung and liver toxicity long-term

  • Brand price often $80 to $200 per month

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.